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Objectives. Wnt/-catenin signalling plays important roles in regeneration, particularly in
hard  tissues such as bone and teeth, and can be regulated by small molecule antagonists of
glycogen synthase kinase 3 (GSK3); however, small molecules can be difﬁcult to deliver clin-
ically.  Lithium (Li) is also a GSK3 antagonist and can be incorporated into bioactive glasses
(BG),  which can be used clinically in dental and bone repair applications and tuned to quickly
release their constituent ions.
Methods. Here, we created phosphate (P)- and borate (B)-based BG that also contained Li
(LiPBG and LiBBG) and examined their ion release kinetics and the toxicity of their dissolu-
tion  ions on mouse 17IA4 dental pulp cells.
Results. We  found that although LiPBG and LiBBG can both quickly release Li at concen-
trations known to regulate Wnt/-catenin signalling, the P and B ions they concomitantly
release are highly toxic to cells. Only when relatively low concentrations of LiPBG and LiBBG
were placed in cell culture medium were their dissolution products non-toxic. However, at
these concentrations, LiPBG and LiBBG’s ability to regulate Wnt/-catenin signalling waslimited.
Signiﬁcance. These data suggest that identifying a BG composition that can both quickly
deliver high concentrations of Li and is non-toxic remains a challenge.
©  2019 The Academy of Dental Materials. Published by Elsevier Inc. This is an open access
nderarticle u
.  Introdctionnt/-catenin signalling is fundamental in numerous cellular
rocesses, particularly in the context of hard tissue regen-
ration [1]. Indeed, regulation of Wnt/-catenin signalling
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has been shown to stimulate both bone regeneration to ﬁx
metallic implants in place [2] and encourage dentine forma-
tion [3]. Wnt/-catenin signalling can be modulated by small
molecule glycogen synthase kinase (GSK3) antagonists such as
BIO, CHIR99021, and Tideglusib [4]. Indeed, this strategy was
employed by Neves et al. who showed that GSK3 antagonists
adsorbed onto a collagen sponge and placed into a defect in
a mouse molar mediated complete repair of the dentine via
regulation of Wnt/-catenin signaling [3]. As delivery in this
context relied on physical adsorption to the scaffold, burst
vier Inc. This is an open access article under the CC BY license
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delivery of GSK3 antagonists to the injury site may have been
important in stimulating dentine regeneration. However, in
Neves et al.’s study, small molecule-mediated repair required
a material carrier and the drug had to be delivered directly
into the pulp chamber to be effective. Therefore, this strat-
egy may be limited to a subset of clinical contexts in which
the pulp chamber is already exposed. Like BIO, CHIR99021 and
Tideglusib, lithium (Li) has similarly been shown to be a GSK3
antagonist, regulate Wnt/-catenin signalling, and stimulate
hard tissue formation [5,6]. Moreover, Li can potentially be
incorporated into and released from existing dental materi-
als, precluding the need for a collagen sponge to be surgically
implanted into the tooth. Therefore, a material that could
quickly release Li might be efﬁcacious in regulating Wnt/-
catenin signalling and promoting tissue repair, particularly in
hard tissues such as bone and teeth.
Bioactive glasses (BG) are widely used in dental and bone
restorations [7,8]. BG’s bioactive properties are derived from a
combination of their surface reactive properties, which allow
them to directly bond to living tissue via the formation of a
hydroxyapatite surface layer, and their ability to release ther-
apeutic ions, which can direct cellular responses. Indeed, Ca, P
and Si released from BG [9,10], as well as ions released from BG
with various ionic substitutions, including strontium [11–13],
ﬂuoride [14] and cobalt [15,16], have all shown promise in
regenerative applications. Most BG explored for biomedical
applications, including 45S5 Bioglass
®
, are based on silicate.
Li can be substituted into standard silicate-based BG in place
of sodium, and we and others have shown that Li-substituted
BG (LiBG) release Li ions, regulating Wnt/-catenin signaling
[17,18]. However, whilst in our hands, Li ions in the form of LiCl
upregulated expression of the Wnt/-catenin signalling tar-
get gene AXIN2 in 17IA4 mouse dental pulp cells by as much
as 15-fold, Li released from Si-based LiBG only upregulated
AXIN2 expression approximately 2-fold. This is likely because
Si-based LiBG can only release a limited amount of Li because
they dissolve relatively slowly and form a hydroxyapatite layer
on their surface, which can hinder further release [7]. There-
fore, although efﬁcacious in many  applications, when quick,
high levels of ion release are required, Si-based LiBG may only
be minimally efﬁcacious. Increasing the local concentration of
BG particles can yield higher levels of ion release; however, this
can also produce local increases in pH. Whilst slightly alkaline
conditions may be preferable for promoting the formation of
biological apatites, excess alkalinity can be biologically toxic
[19].
Phosphate (P) and borate (B) are alternative bases for BG
and have been developed for biomedical applications [20–22].
Unlike Si-based BG which often dissolve slowly, phosphate
(PBG) and borate (BBG) BG solubility can be tuned so that
they dissolve quickly in biological solutions [23–26], poten-
tially allowing for quicker and higher levels of Li release.
Moreover, both PBG and BBG can potentially enhance hard tis-
sue formation themselves. P is a macronutrient essential for
physiological functions such as skeletal development, min-
eral metabolism and cell signaling [27,28], and dietary intake
of B plays important roles in bone formation and mainte-
nance [29–31]. PBG have been formed with good bioactivity
and biocompatibility and have been proposed for bone repair
and reconstruction [32,33]. Similarly, BBG have been shown5 ( 2 0 1 9 ) 919–927
to promote the osteogenic differentiation of human mes-
enchymal stem cells in vitro [39], used to treat osteomyelitis
in a rabbit model in vivo [34], and employed to repair cal-
varial defects in mice [42,43]. Moreover, BBG are potentially
angiogenic [26], which when combined with LiBG, which have
also been reported to be angiogenic [35], may aid in tissue
regeneration. Li can easily be incorporated into melt-derived
PBG and BBG (LiPBG and LiBBG), potentially combining the
hard-tissue regenerating properties of PBG and BBG with the
Wnt/-catenin signalling regulatory effects of Li.
The concentration of Li that must be released from a
BG to regulate the Wnt/-catenin signalling is controversial.
Patients on Li therapy for psychological disorders have con-
centrations of Li in their serum of ∼0.8 mM (5.5 ppm) and
enhanced bone mass [36]. However, the seminal study which
identiﬁed Li as regulator of Wnt/-catenin signalling and
showed Li-mediated increases in bone mass in mice, reported
that 20 mM LiCl (139 ppm) was necessary to upregulate mark-
ers of osteogenesis in mouse calvarial osteoblasts [5]. When
released from LiBG, Han et al. reported that just 17 ppm Li
was sufﬁcient to promote the cementogenic differentiation of
periodontal ligament cells [18]. Others have similarly reported
that when released from sol-gel derived BG, 5 mM Li (35 ppm)
could stimulate a mouse chondrocyte cell line to form a
cartilage-like matrix in pellet culture, in the absence of TGF-3
stimulation [37]. When da Silva et al. examined the expression
of AXIN2,  which interacts with GSK3 [38] and plays a central
role in Wnt/-catenin signalling, they found that expression
was only marginally upregulated at concentrations between
20 and 50 mM [17]. However, when 17IA4 cells were exposed to
100 mM LiCl (694 ppm), they upregulated expression of AXIN2
more than 15 fold. Here, we  investigated the ion release and
biocompatibility of LiPBG and LiBBG to determine their poten-
tial to regulate Wnt/-catenin signalling for hard tissue repair.
We  show that although LiPBG and LiBBG can quickly release
high levels of Li, the concomitant high levels of P and B they
release are toxic to 17IA4 mouse dental pulp cells. These ﬁnd-
ings suggest that the therapeutic potential of highly soluble
LiPBG and LiBBG for regulating hard tissue regeneration via
Wnt/-catenin signalling may be limited.
2.  Materials  and  methods
2.1.  BG  synthesis  and  characterisation
Binary glass compositions (Table 1) were chosen to maximise
Li ion content in the glass and were prepared by a conven-
tional melt-quench route. High purity precursor components
H3BO4 (Riedel-de-Haen), Li2CO3 (Carl Roth) and NH4H2PO4
(Carl Roth) were melted in an electrical furnace at 1000–1100 ◦C
in fused silica (PBG) or platinum (BBG) crucibles for about
1 h and subsequently quenched between brass plates to pre-
vent crystallisation. PBG were annealed at about 400 ◦C and
allowed to cool to room temperature overnight. Glasses were
then crushed in stainless steel mortars, ground in an agate
ball mill (Janetzki KM1, Germany) for 40 min  and sieved to
< 38 m using stainless steel sieves. Si-based LiBG was pre-
pared as described earlier [17] and compositions with 100%
substitution of Li for Na were used here.
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Table 1 – Nominal BG compositions (in mol%) and Li content.
Glass P2O5 B2O3 SiO2 Li2O CaO Li content (mg  Li/mg glass) Li content (mmol  Li/mg glass)
PLi55 45 55 0.095 0.660
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wPLi50 50 50 
BLi45 55 45 
Si-LiBG 2.6 46.1 24.4 26.9 
.2.  Cell  culture
ll experiments were performed with the mouse dental pulp
ell line, 17IA4 [39]. Cells were cultured under standard con-
itions (5% CO2/95%, 37 ◦C, humidiﬁed atmosphere) in alpha
inimum essential medium (MEM)  supplemented with 10%
v/v) foetal bovine serum (FBS) and 2 mM l-glutamine (all from
hermo Fisher Scientiﬁc).
.3.  Preparation  of  BG-conditioned  medium
G-conditioned media were created by soaking the indicated
oncentration of BG particles in MEM.  Media with BG parti-
les were maintained on a laboratory tube roller at 37 ◦C for
he indicated time period and then passed through a 0.22 m
yringe ﬁlter prior to ICP-MS or cell culture experiments. Mea-
urements of pH were carried out on a standard laboratory pH
etre. In some experiments, PBG was simultaneously soaked
ith Si-based LiBG at the indicated concentrations.
.4.  Elemental  analysis  by  inductively  coupled  plasma
ass  spectrometry  (ICP-MS)
oncentrations of calcium (Ca), phosphorus (P), lithium (Li),
nd borate (B) in cell culture media were determined by ICP-
S on a Perkin-Elmer NexION 350D using a CETAC AX520
utosampler, using customary calibration standards. Solu-
ions were diluted 1:100 with a 1% nitric acid solution prior
o analysis. Data were analysed in Syngistix software.
.5.  Cytotoxicity  testing  based  on  ISO10993:5
ytotoxicity testing of dissolution ion medium was carried
ut as previously described [40,41], using a modiﬁed version
f ISO10993:5. Positive and negative control materials were
indly provided by Raumedic AG (Helmbrechts, Germany)
nd consisted of organotin-stabilised polyvinyl chloride (PVC)
heet and non-toxic (Med7536 noDop) polymer tubing, respec-
ively. To create positive and negative control media a surface
rea to volume ratio of 3 cm2/mL  of control materials (ster-
lised in 70% ethanol for 1 h and rinsed with sterile phosphate
uffered saline, PBS) were soaked in MEM  for 7 days under
tandard culture conditions. To test the toxicity of dissolu-
ion ion medium, 17IA4 cells were plated in 96-well plates at
0,000 cells/cm2 and allowed to attach for 24 h. The cell culture
edium was then replaced with either positive or negative
ontrol medium or dissolution ion medium supplemented
ith 10% FBS and 2 mM l-glutamine. After an additional 24 h,
0 L of a 5 mg/mL  solution of MTT  (3-(4,5-dimethylthiazol-2-
l)-2,5-diphenyltetrazolium bromide, Sigma) in PBS was added
o each well and allowed to incubate for 4 h. Culture medium
as then removed and replaced with 200 L dimethyl sulfox-81 0.561
21 0.838
63 0.437
ide (Sigma) and the absorbance of the product was measured
on a colorimetric plate reader at 540 nm.
2.6.  Gene  expression  analyses
17IA4 were plated at 25,000 cells/cm2 in 12 well plates
in basal culture medium and allowed to attach for 24 h
under standard conditions. Thereafter, the medium was
replaced with conditioned or control medium and cells
were cultured for an additional 24 h. 1 mL TRIzol (15596026,
Thermo Fisher Scientiﬁc) was then added to each well
and cell lysates stored at −20 ◦C. RNA was extracted
according to manufacturer’s instructions, quantiﬁed by
Nanodrop and reversed transcribed into cDNA using ran-
dom primers (M-MLV Reverse Transcriptase Kit, Promega).
qPCR was performed in a reaction mixture consisting of
5 L SYBR Green Master Mix  (KAPA SYBR® FAST qPCR kit),
0.1 L forward primers, 0.1 L reverse primers and 4.8 L
cDNA. Beta-actin (forward—GGCTGTATTCCCCTCCATCG,
reverse—CCAGTTGGTAACAATGCCTGT) and AXIN2
primers (forward—TGACTCTCCTTCCAGATCCCA,
reverse—TGCCCACACTAGGCTGACA) were used. BioRad
and Kappa Syber Fast (Kappa Biosystems) software were
used for quantitative analysis. Reactions were performed in
triplicate, and relative changes in expression of AXIN2 to that
of the beta-actin were calculated using the C T method.
2.7.  Statistical  analyses
All data are presented as means with standard deviations and
were collected from at least three independent experiments.
Statistical analyses were carried out using one-way analysis of
variance followed by post-hoc Tukey test for multiple compar-
isons, or a t-test when comparing 2 groups. Differences were
considered signiﬁcant if p < 0.05.
3.  Results
BG compositions are shown in Table 1; compositions with
higher Li contents could not be obtained in an amorphous
state owing to spontaneous crystallisation during quenching.
Absolute Li content (in mg  Li per mg  glass) was highest in
borate glass BLi45, followed by the two phosphate glasses,
PLi55 and PLi50.
We  have previously shown that Li release from Si-based
LiBG is both particle-size dependent and relatively slow [17].
A quicker release can be achieved by decreasing particle size,
but equilibrium still requires hours (particle size <38 m)  to
days (particle size 0.1–10 mm)  [17]. Therefore, we ﬁrst aimed
to determine the Li-release proﬁle from LiPBG and LiBBG. Both
LiPBG and LiBBG dissolved quickly in cell culture medium
(Fig. 1a–d). That is, within 4 h, all compositions resulted in con-
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Fig. 1 – Elemental concentrations of a) Ca, b) Li, c) P and d) B in cell culture medium after 6 mg/mL  LiPBG and LiBBG were
soaked for up to 24 h.
centrations of Li in cell culture medium of more  than 500 ppm,
which did not change signiﬁcantly over 24 h. Similarly, con-
centrations of Ca, P and B in cell culture media remained
stable after 4 h. These data suggest that unlike Si-based LiBG,
which dissolve slowly, LiPBG and LiBBG dissolve quickly upon
exposure to cell culture medium, releasing their constitutive
ions. Moreover, the concentration of Li released from LiPBG
and LiBBG was higher than that which has been achieved
with Si-based LiBG when incubated at the same concentra-
tion (6 mg/mL). Indeed, Si-based LiBG in which 100% of the Na
was substituted with Li was never able to release more  than
∼300 ppm Li from the same size particles over 7 days, even
when 10 times (60 mg/mL) the concentration of BG was placed
in cell culture medium [17]. Therefore, LiPBG and LiBBG can
achieve quicker and higher levels of Li release than Si-based
LiBG.
We next aimed to determine whether the dissolution prod-
ucts from LiPBG and LiBBG were toxic. Therefore, we soaked
BG particles in cell culture medium for 24 h, placed their disso-
lution products on 17IA4 mouse dental pulp cells and assessed
their viability according to ISO10993:5. The dissolution prod-
ucts of 6 mg/mL  LiPBG and LiBBG were highly toxic to cells.
Indeed, the metabolic activity of 17IA4 cells exposed to these
dissolution products were signiﬁcantly different than that
of negative control cells exposed to non-toxic polymers, but
were no different from that of cells exposed to toxic mate-
rial controls (Fig. 2a). Reducing the concentration of glass in
medium to 3 mg/mL  and 1.5 mg/mL  could not rescue cells.
Indeed, only when the concentration of LiPBG and LiBBG
soaked with cell culture medium was reduced to 0.75 mg/mLdid we ﬁnd the metabolic activity of 17IA4 cells exposed to the
dissolution products LiPBG and LiBBG to be no different from
that of negative controls. Our previous work had shown that
the dissolution products of Si-based LiBG were non-toxic at
6 mg/mL, but at higher concentrations, toxicity was mediated
by changes in the pH of cell culture medium [17]. Therefore, to
determine if changes in pH could have been responsible for the
toxicity of LiPBG and LiBBG here, we tested medium pH. The
pH of dissolution ion medium from all concentrations of LiPBG
and LiBBG, however, did not change as a function of BG con-
centration (Fig. 2b), suggesting that toxicity was not mediated
by changes in pH.
As changes in pH could not explain the toxicity of LiPBG
and LiBBG, we  next examined the concentrations of other ions
in solution as we  decreased the concentrations of LiPBG and
LiBBG soaked in cell culture medium from toxic to non-toxic
levels. The concentration of Ca remained stable in all groups as
we decreased the concentration of BG in the medium (Fig. 3a).
This is because unlike Si-based BG, LiPBG and LiBBG used here
did not contain Ca and so do not release extra Ca into the
medium. This was in contrast with Li concentrations, which
decreased as expected for all LiPBG and LiBBG formulations
(Fig. 3b). B concentrations similarly decreased as we  decreased
the concentration of LiBBG in media (Fig. 3d); and in LiPBG
formulations, P decreased from ∼3000–4000 ppm in 6 mg/mL
conditions to 300–400 ppm in 0.75 mg/mL  conditions (Fig. 3c).
da Silva has previously shown that Li is non-toxic to 17IA4
cells at concentrations as high as 700 ppm [17], suggesting that
toxicity could not be explained by the Li released from the BG.
B is not strictly essential in mammals, but is ubiquitous in
d e n t a l m a t e r i a l s 3 5 
Fig. 2 – a) Normalised metabolic activity of 17IA4 cells after
24 h treatment with the dissolution products of differing
concentrations of LiPBG and LiBBG. For all BG compositions
at 0.75 mg/mL, metabolic activity was no different than that
of negative controls. At concentrations above 0.75 mg/mL,
metabolic activity was always different from that of
negative controls and no different from that of positive
controls, p < 0.05. b) pH of control (MEM)  and dissolution
ion medium formed from soaking various concentrations of
LiPBG and LiBBG.
Fig. 3 – Elemental concentrations of a) Ca, b) Li, c) P, and d) B in ce
of LiPBG and LiBBG.( 2 0 1 9 ) 919–927 923
fruits, vegetables and drinking water [42] and B deﬁciency can
negatively impact bone development and growth [29]. Never-
theless, B is also known to toxic at high concentrations [43].
Similar dose-dependent effects have also been observed with
P, as whilst P is an essential nutrient and plays central roles
in a myriad of biological activities, from cell metabolism to
cell signalling, P is known to be toxic if present in excessive
concentrations [44]. These data therefore suggest that toxicity
of the LiPBG and LiBBG may have been mediated by the high
concentrations of B and P released from the BG themselves.
To lend further support to our hypothesis that high levels
of P mediated the toxicity of their dissolution ion medium,
we next combined the toxic concentration of 1.5 mg/mL  LiPBG
with 4.5 mg/mL  Si-based LiBG to create a co-dissolution ion
medium, as LiBG particles precipitate phosphorus out of cell
culture medium by forming a hydroxyapatite layer on their
surface as they dissolve [11]. ICP-MS analyses showed that Ca
levels remained stable (Fig. 4a), and Li levels increased (Fig. 4b)
when Si-based LiBG were co-dissolved with LiPBG. Moreover,
in line with the expected precipitation of CaP on Si-based
LiBG, the concentration of P in medium that had been con-
ditioned with both LiPBG and Si-based LiBG decreased from
∼900 ppm to less than 500 ppm (Fig. 4c). When we  repeated
the ISO10993:5 toxicity test with this new co-dissolution ion
medium, we found that although metabolic activity levels
of cells exposed to the mixed glass medium were still sig-
niﬁcantly lower than that in negative controls, they were
signiﬁcantly higher than that of cells exposed to toxic posi-
tive controls (Fig. 4d). These observations strongly suggest that
the toxicity of LiPBG was mediated by the high levels of P ions
released from them.
To determine if non-toxic concentrations of Li released
from LiPBG and LiBBG could regulate Wnt/-catenin sig-
nalling, we next analysed AXIN2 expression in 17IA4 cells in
response to treatment with dissolution products from non-
toxic 0.75 mg/mL  LiPBG and LiBBG (Fig. 4e). qPCR analyses
showed that AXIN2 was upregulated approximately 3 fold in
ll culture medium after exposure to varying concentrations
924  d e n t a l m a t e r i a l s 3 5 ( 2 0 1 9 ) 919–927
Fig. 4 – Elemental concentrations of a) Ca, b) Li and c) P in dissolution ion medium that either contained 1.5 mg/mL  of LiPBG
(P BG alone) or combined 1.5 mg/mL  LiPBG with 4.5 mg/mL  Si-based LiBG (P+Si BG). d) Normalised metabolic activity of
17IA4 cells after 24 h of treatment with the dissolution products from either medium that either contained 1.5 mg/mL  of
LiPBG or combined 1.5 mg/mL  LiPBG with 4.5 mg/mL  Si-based LiBG. Metabolic activity in both compositions of LiPBG were
signiﬁcantly lower than that of negative controls, even when Si-based LiBG was co-dissolved (not shown, p < 0.05);
however, metabolic activity in the LiPBG + Si LiBG was signiﬁcantly higher than that of positive (toxic) controls. e) qPCR
PBG analyses for AXIN2 expression in 17IA4 cells treated with Li
response to both LiPBG and LiBBG. These observations suggest
that although only relatively low levels of Li could be released
from LiPBG and LiBBG, whilst still remaining non-toxic, these
levels were sufﬁcient to mildly upregulate Wnt/-catenin sig-
nalling.
4.  Discussion
In order to maximise Li content in (and thus, possibly, Li ion
release from) BG, binary phosphate and borate BG composi-
tions were chosen containing Li2O as the only metal oxide.
For LiPBG, two compositions with variable Li2O content (55 vs.
50 mol%) were chosen. This also potentially allows for varia-
tion of the ion release behaviour, as PBG with 45 or 50 mol% of
P2O5 have been shown to differ in their dissolution behaviour
[45–47]. The Li2O content in BBG and Si-based BG was lower
(45 and 24.4 mol%, respectively) than in PBG, as compositionsand LiBBG dissolved in cell culture media at 0.75 mg/mL.
with higher contents crystallised spontaneously during prepa-
ration. Indeed, it is known that unlike for borate and silicate
glasses, phosphate glasses with very high metal oxide con-
tents can be prepared successfully [48,49].
Phosphate or borate BG differ from silicate BG in their dis-
solution behaviour. That is, whilst Si-based glasses release
ions via an ion exchange mechanism, P- and B-based glass
dissolution involves degradation of the actual glass network
[45,50,51], potentially allowing for fast ion release bursts. Here,
LiPBG and LiBBG released ions into cell culture medium very
quickly and at higher concentrations than equivalent mass
to volume ratios of Si-based LiBG. Indeed, whilst we  have
previously shown that 6 mg/mL of Si-based LiBG (particles
0.1–1 mm in diameter) resulted in concentrations of Li in
solution of ∼5 ppm [17], placing the equivalent concentra-
tions of LiPBG and LiBBG (particles <38 m in diameter) in
cell culture medium yielded between ∼600 and 800 ppm Li.
However, whereas the dissolution products from as much as
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[1] Clevers H, Loh KM, Nusse R. An integral program for tissue
renewal and regeneration: Wnt  signaling and stem celld e n t a l m a t e r i a l s 
0 mg/mL  of Si-based LiBG was non-toxic to cells, the disso-
ution products of just 6 mg/mL  LiBBG and LiPBG were highly
oxic. Indeed, the toxicity of dissolution products from LiPBG
nd LiBBG were no different from negative controls only when
e used a fraction of the concentration that for Si-based LiBG
emained non-toxic. Therefore, whilst 6 mg/mL  of LiPBG and
iBBG can release levels of Li that we  have previously shown to
trongly regulate Wnt/-catenin signalling [17], such dissolu-
ion products are highly toxic. Only when dissolution products
rom far lower concentrations of LiPBG and LiBBG particles
ere employed, were they non-toxic. However, the levels of
i released under these conditions (although still higher than
hose released from Si-based LiBG) were still relatively low.
aken together, these observations suggest that we have not
dentiﬁed an ideal Li-containing BG composition that can both
uickly release high concentrations of Li and remain non-toxic
o cells.
Others have reported on the development and characteri-
ation of PBG [21,22] and BBG [20,26,52,53] for biomedical use.
n line with our observations, Salih et al. reported that PBG
ith high dissolution rates were toxic to 2 human osteoblast-
ike cell lines [22]. However, in studies in which BBG have been
ormed into scaffolds and cements, authors report little to no
ell toxicity. These observations suggest that the solubility of
he BG and the context within which it is employed are key in
BG and BBG toxicity.
Our elemental analyses of LiPBG and LiBBG dissolution
on medium combined with ISO10993:5 tests using medium
n which LiPBG and Si-based LiBG were co-dissolved, suggest
hat LiPBG and LiBBG toxicity was mediated by the high lev-
ls of P and B released from the BG. The concentration of B
n ground water varies from <0.3 to >100 mg/L, but is gen-
rally in the range of 1 mg/L [54], and its concentration in
oil varies between 2 and 100 ppm [55]. This results in serum
evels in healthy individuals ranging between approximately
0 and 200 g/L [56]. There are no recommended intake lev-
ls for boron, but adults generally consume 1–2 mg/day [57],
nd upper limits are suggested to be no more  than 20 mg/day
58]. The concentrations of B in dissolution ion media that
ere toxic to cells in our experiments were orders of magni-
ude higher than that which would be expected in serum due
o normal exposure. When we lowered the concentration of
iBBG in cell culture medium; however, we  were able to iden-
ify a level at which dissolution products were no longer toxic.
ndeed, at 3 mg/mL  (1368 ppm), media were highly toxic. When
.5 mg/mL  of LiBBG were added (490 ppm), toxicity was much
bated; however, at 0.75 mg/mL  (247 ppm) dissolution prod-
cts were no longer toxic. The concentration of B in these
issolution products and our observations of their toxicity
ere directly in line with the predicted fatal serum concen-
rations of B in humans, which have been reported to be
0 mg/dL [59] (500 ppm). Similarly, whilst P is an essential
utrient which normally exists in human serum in the range
f 2.5–4.5 mg/dL; it can also be toxic at high concentrations.
lthough the pathophysiology of phosphorus imbalances in
he body are complex, the concentrations released from LiPBG
hat we  report here to be toxic to 17IA4 cells are far higher than
hysiological levels, which are normally tightly controlled [60].
When we co-dissolved LiPBG with Si-based LiBG we were
ble to achieve higher levels of Li release than LiPBG compo-( 2 0 1 9 ) 919–927 925
sitions alone and reduced levels of toxicity, likely owing to
precipitation of toxic P out of solution. These observations
suggest that although a single optimised composition of BG
that can both quickly release high levels of Li and remain non-
toxic to cells remains elusive, combinations of Si-based LiBG,
LiPBG and LiBBG may counterbalance some of the negative
aspects of some compositions whilst harnessing their posi-
tive effects. Future strategies may ﬁnd success pursuing such
combinations.
Despite the fact that LiPBG and LiBBG that released high
levels of Li also released toxic levels of B and P, dissolution
ion medium created from lower concentrations of LiPBG and
LiBBG were still able to upregulate AXIN2 expression in 17IA4.
Therefore, although we were unable to create a BG that both
quickly released large amounts of Li without releasing toxic
levels of P and B, LiPBG and LiBBG may still ﬁnd use in reg-
ulating hard tissue formation via modulating Wnt/-catenin
signalling. This is in keeping with previous reports that Li-
releasing BG can upregulate Wnt/-catenin [17] and stimulate
tissue regeneration [61,62], even when Li levels are relatively
low.
5.  Conclusions
Here we developed BG based on B and P that could quickly
release high levels of Li, which is a known GSK3 antagonist,
and thus regulate Wnt/-catenin signalling. Our ﬁndings show
that whilst it was possible to quickly release high levels of Li
from both LiPBG and LiBBG, they concomitantly released toxic
levels of P and B, limiting their utility in hard tissue repair.
We conclude that although it was possible to create non-toxic
LiPBG and LiBBG that could subtly upregulate AXIN2 expres-
sion, we  have not yet identiﬁed an ideal BG formulation that
can both provide a burst release of high levels of Li whilst not
simultaneously releasing toxic levels of B and P.
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